Overview

Hemolens Diagnostics pioneered a revolutionary non-invasive technology utilizing Biomedical Engineering (BME) and Computational Fluid Dynamics (CFD) to evaluate Coronary Artery Disease (CAD).
Hemolens’s unique non-invasive diagnostic method drives a digital transformation and innovation not only to Cardiology but also can be scaled up to Oncology, Pulmonology, Angiology, and Neurology.